Retinitis Pigmentosa (RP) Not Yet Recruiting Phase 0 Trials for Ginkgo biloba (DB01381)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Not Yet Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02465749Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis PigmentosaTreatment